| ISIN | US48817R7061 |
|---|---|
| TER | 0.01% |
| Replication | Synthetic |
| Distribution | Accumulating |
| Launch Year | 2022 |
| AUM | $0.00 billion |
| Provider | Strategic |
| Exchange | Toronto Exchange (Canada) |
| Currency | CAD |
| Country | Canada |
| Type | ETF |
The adviser employs a "passive management" investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Consult fund provider.
| Period | Return (%) |
|---|---|
| 1 Month | 0.00% |
| 3 Months | 0.00% |
| 6 Months | 0.00% |
| 1 Year | 0.00% |
| 3 Years | -22.85% |
| 5 Years | N/A |
| Since Inception | -50.75% |
Distribution: Accumulating
Volatility and risk metrics are calculated based on historical price movements.
This ETF is widely available on major European brokers like Trade Republic, Scalable, and DEGIRO.
Compare brokers →Exchange: Toronto Exchange (Canada)
Currency: CAD
Is this ETF accumulating?
Yes, it reinvests dividends.